Sign in to our online system or register for a new account to submit a letter of intent.
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies that have excellent preliminary data.
NEW for 2018:
Goal: To provide funding to support clinical trials and/or clinical trial sub-studies that could accelerate the development of therapeutics for neurodegenerative disease aging.
Funding: A maximum of $1,500,000 per project over up to 4 years
Eligible Principal Applicants must be at or above the level of Assistant Professor or equivalent, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada. Co-applicants and Collaborators must be at the post-doctoral level or above, and can be working outside Canada.
Applicants may appear in any role on any number of projects.
Projects must meet these conditions to be eligible:
Please refer to the What We Fund page for Institute definitions of neurodegenerative diseases of aging, translational research, therapeutic, tool, and clinical trials.
The Institute encourages applicants to contact us (firstname.lastname@example.org or +1 416-935-4056) with any questions regarding this program, including whether a potential idea is in scope.
There are two stages to the application process:
An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be forwarded to those invited.
Applicants can expect to receive the outcome of their LOI application within ~2 months of submission.
The Institute welcomes inquiries about this program or any of our other funding opportunities. Contact us at email@example.com or +1 416-935-4056.